These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 1918952)

  • 1. Human eosinophil cytotoxicity-enhancing factor. II. Multiple forms synthesized by U937 cells and their relationship to thioredoxin/adult T cell leukemia-derived factor.
    Balcewicz-Sablinska MK; Wollman EE; Gorti R; Silberstein DS
    J Immunol; 1991 Oct; 147(7):2170-4. PubMed ID: 1918952
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human eosinophil cytotoxicity-enhancing factor. Purification, physical characteristics, and partial amino acid sequence of an active polypeptide.
    Silberstein DS; Ali MH; Baker SL; David JR
    J Immunol; 1989 Aug; 143(3):979-83. PubMed ID: 2745979
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Eosinophil cytotoxicity enhancing factor: purification, characterization and immunocytochemical localization on the monocyte surface.
    Elsas PX; Elsas MI; Dessein AJ
    Eur J Immunol; 1990 May; 20(5):1143-51. PubMed ID: 2192904
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of a factor from the U937 cell line that enhances the toxicity of human eosinophils to Schistosoma mansoni larvae.
    Silberstein DS; Dessein AJ; Elsas PP; Fontaine B; David JR
    J Immunol; 1987 May; 138(9):3042-50. PubMed ID: 3494778
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human eosinophil cytotoxicity-enhancing factor. Eosinophil-stimulating and dithiol reductase activities of biosynthetic (recombinant) species with COOH-terminal deletions.
    Silberstein DS; McDonough S; Minkoff MS; Balcewicz-Sablinska MK
    J Biol Chem; 1993 Apr; 268(12):9138-42. PubMed ID: 8473353
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Purification and characterization of a unique human interleukin 1 from the tumor cell line U937.
    Knudsen PJ; Dinarello CA; Strom TB
    J Immunol; 1986 May; 136(9):3311-6. PubMed ID: 3485687
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selection of U937 histiocytic lymphoma cells highly responsive to phorbol ester-induced differentiation using monoclonal antibody to the eosinophil cytotoxicity-enhancing factor.
    Elsas MI; Dessein AJ; Elsas PX
    Blood; 1990 Jun; 75(12):2427-33. PubMed ID: 2190641
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Opposing regulatory effects of thioredoxin and eosinophil cytotoxicity-enhancing factor on the development of human immunodeficiency virus 1.
    Newman GW; Balcewicz-Sablinska MK; Guarnaccia JR; Remold HG; Silberstein DS
    J Exp Med; 1994 Jul; 180(1):359-63. PubMed ID: 8006594
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of tumor-derived cytokines on the immune system of mice bearing a mammary adenocarcinoma. II. Down-regulation of macrophage-mediated cytotoxicity by tumor-derived granulocyte-macrophage colony-stimulating factor.
    Sotomayor EM; Fu YX; Lopez-Cepero M; Herbert L; Jimenez JJ; Albarracin C; Lopez DM
    J Immunol; 1991 Oct; 147(8):2816-23. PubMed ID: 1918995
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thioredoxin expression and localization in human cell lines: detection of full-length and truncated species.
    Sahaf B; Söderberg A; Spyrou G; Barral AM; Pekkari K; Holmgren A; Rosén A
    Exp Cell Res; 1997 Oct; 236(1):181-92. PubMed ID: 9344598
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhancement of human eosinophil cytotoxicity and leukotriene synthesis by biosynthetic (recombinant) granulocyte-macrophage colony-stimulating factor.
    Silberstein DS; Owen WF; Gasson JC; DiPersio JF; Golde DW; Bina JC; Soberman R; Austen KF; David JR
    J Immunol; 1986 Nov; 137(10):3290-4. PubMed ID: 3095427
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of eosinophil migration by adult T cell leukemia-derived factor.
    Hori K; Hirashima M; Ueno M; Matsuda M; Waga S; Tsurufuji S; Yodoi J
    J Immunol; 1993 Nov; 151(10):5624-30. PubMed ID: 8228251
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor necrosis factor as effector molecule in monocyte mediated cytotoxicity.
    Ziegler-Heitbrock HW; Möller A; Linke RP; Haas JG; Rieber EP; Riethmüller G
    Cancer Res; 1986 Nov; 46(11):5947-52. PubMed ID: 3756932
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A synthetic peptide, FN-C/H-V, from the C-terminal heparin-binding domain of fibronectin promotes adhesion of PMA stimulated U937 cells.
    Kato K; Mohri H; Tamura T; Okubo T
    Biochem Biophys Res Commun; 1997 Oct; 239(1):205-11. PubMed ID: 9345296
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of expression of IL-1 receptor antagonist protein in human synovial and dermal fibroblasts.
    Krzesicki RF; Hatfield CA; Bienkowski MJ; McGuire JC; Winterrowd GE; Chapman DL; Berger AE; McEwan RN; Carter DB; Chosay JG
    J Immunol; 1993 May; 150(9):4008-18. PubMed ID: 8473746
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression and co-cytokine function of murine thioredoxin/adult T cell leukaemia-derived factor (ADF).
    Blum H; Röllinghoff M; Gessner A
    Cytokine; 1996 Jan; 8(1):6-13. PubMed ID: 8742061
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Beta-ig. Molecular cloning and in situ hybridization in corneal tissues.
    Rawe IM; Zhan Q; Burrows R; Bennett K; Cintron C
    Invest Ophthalmol Vis Sci; 1997 Apr; 38(5):893-900. PubMed ID: 9112985
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Constitutive production of human interleukin for DA cells/leukemia inhibitory factor by human tumor cell lines derived from various tissues.
    Gascan H; Anegón I; Praloran V; Naulet J; Godard A; Soulillou JP; Jacques Y
    J Immunol; 1990 Apr; 144(7):2592-8. PubMed ID: 2156925
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of the receptor for tumor necrosis factor (TNF) and lymphotoxin (LT) on human T lymphocytes. TNF and LT differ in their receptor binding properties and the induction of MHC class I proteins on a human CD4+ T cell hybridoma.
    Andrews JS; Berger AE; Ware CF
    J Immunol; 1990 Apr; 144(7):2582-91. PubMed ID: 1969453
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extracellular matrix-associated serine protease inhibitors (Mr 33,000, 31,000, and 27,000) are single-gene products with differential glycosylation: cDNA cloning of the 33-kDa inhibitor reveals its identity to tissue factor pathway inhibitor-2.
    Rao CN; Reddy P; Liu Y; O'Toole E; Reeder D; Foster DC; Kisiel W; Woodley DT
    Arch Biochem Biophys; 1996 Nov; 335(1):82-92. PubMed ID: 8914837
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.